Diverticulitis risk for JAK inhibitor

Baricitinib (Olumiant) should be used with caution in patients with diverticular disease, regulators in the UK have advised The drug safety update from the Medicines and Healthcare products Regulatory Agency (MHRA) also says the JAK inhibitor should also be used in caution in patients concomitantly treated with medications associated with an increased risk of diverticulitis ...

Already a member?

Login to keep reading.

© 2021 the limbic